Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.

Win N, Lee E, Needs M, Chia LW, Stasi R.

Transfus Med. 2012 Apr;22(2):137-41. doi: 10.1111/j.1365-3148.2011.01131.x. Epub 2012 Jan 10.

PMID:
22233101
2.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

PMID:
12777582
3.

Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.

Win N, Sinha S, Lee E, Mills W.

Transfus Med Rev. 2010 Jan;24(1):64-7. doi: 10.1016/j.tmrv.2009.09.006. Review.

PMID:
19962576
4.
5.

Hyperhemolytic transfusion reaction in sickle cell disease.

Win N, Doughty H, Telfer P, Wild BJ, Pearson TC.

Transfusion. 2001 Mar;41(3):323-8.

PMID:
11274584
6.

Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.

Win N, New H, Lee E, de la Fuente J.

Transfusion. 2008 Jun;48(6):1231-8. doi: 10.1111/j.1537-2995.2008.01693.x. Epub 2008 Mar 25.

PMID:
18373500
8.

Serum ferritin concentration in sickle cell crisis.

Brownell A, Lowson S, Brozović M.

J Clin Pathol. 1986 Mar;39(3):253-5.

9.

Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.

Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P.

Haematologica. 2007 Dec;92(12):e132-5.

10.

Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.

Strupp A, Cash K, Uehlinger J.

Transfusion. 1998 Nov-Dec;38(11-12):1022-5.

PMID:
9838931
11.

Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.

Uhlmann EJ, Shenoy S, Goodnough LT.

Transfusion. 2014 Feb;54(2):384-8. doi: 10.1111/trf.12258. Epub 2013 May 21.

PMID:
23692505
12.

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E.

Blood. 2000 Jul 1;96(1):76-9.

13.

Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.

King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM.

Transfusion. 1997 Apr;37(4):376-81.

PMID:
9111274
14.

Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.

Gupta S, Fenves A, Nance ST, Sykes DB, Dzik WS.

Transfusion. 2015 Mar;55(3):623-8. doi: 10.1111/trf.12876. Epub 2014 Sep 26.

PMID:
25257194
15.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.

Transfusion. 2002 Jan;42(1):37-43. Review.

PMID:
11896310
16.

Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.

Ameen R, Al Shemmari S, Al-Bashir A.

Transfusion. 2009 Aug;49(8):1649-54. doi: 10.1111/j.1537-2995.2009.02185.x.

PMID:
19453992
17.

Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance.

Castellino SM, Combs MR, Zimmerman SA, Issitt PD, Ware RE.

Br J Haematol. 1999 Jan;104(1):189-94.

PMID:
10027733
18.

Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.

Hendrickson JE, Hod EA, Perry JR, Ghosh S, Chappa P, Adisa O, Kean LS, Ofori-Acquah SF, Archer DR, Spitalnik SL, Zimring JC.

Transfusion. 2012 Feb;52(2):231-40. doi: 10.1111/j.1537-2995.2011.03255.x. Epub 2011 Jul 25.

19.

Screening with monoclonal anti-Fy3 to provide blood for phenotype-matched transfusions for patients with sickle cell disease.

Sandler SG, Mallory D, Wolfe JS, Byrne P, Lucas DM.

Transfusion. 1997 Apr;37(4):393-7.

PMID:
9111276
20.

Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.

Hilliard LM, Williams BF, Lounsbury AE, Howard TH.

Am J Hematol. 1998 Sep;59(1):28-35.

Supplemental Content

Support Center